BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30279229)

  • 1. Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's Macroglobulinemia.
    Hao M; Barlogie B; Tricot G; Liu L; Qiu L; Shaughnessy JD; Zhan F
    Clin Cancer Res; 2019 Jan; 25(1):201-209. PubMed ID: 30279229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.
    Gutiérrez NC; Ocio EM; de Las Rivas J; Maiso P; Delgado M; Fermiñán E; Arcos MJ; Sánchez ML; Hernández JM; San Miguel JF
    Leukemia; 2007 Mar; 21(3):541-9. PubMed ID: 17252022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analyses in Waldenstrom's macroglobulinemia and other plasma cell dyscrasias.
    Mitsiades CS; Mitsiades N; Treon SP; Anderson KC
    Semin Oncol; 2003 Apr; 30(2):156-60. PubMed ID: 12720127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance.
    Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ
    Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic analysis of Waldenstrom's macroglobulinemia.
    San Miguel JF; Vidriales MB; Ocio E; Mateo G; Sánchez-Guijo F; Sánchez ML; Escribano L; Bárez A; Moro MJ; Hernández J; Aguilera C; Cuello R; García-Frade J; López R; Portero J; Orfao A
    Semin Oncol; 2003 Apr; 30(2):187-95. PubMed ID: 12720134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD5, CD10, and CD23 expression in Waldenstrom's macroglobulinemia.
    Hunter ZR; Branagan AR; Manning R; Patterson CJ; Santos DD; Tournilhac O; Dorfman DM; Treon SP
    Clin Lymphoma; 2005 Mar; 5(4):246-9. PubMed ID: 15794857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transitions in CD45 isoform expression indicate continuous differentiation of a monoclonal CD5+ CD11b+ B lineage in Waldenstrom's macroglobulinemia.
    Jensen GS; Andrews EJ; Mant MJ; Vergidis R; Ledbetter JA; Pilarski LM
    Am J Hematol; 1991 May; 37(1):20-30. PubMed ID: 1708944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
    N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences.
    Kriangkum J; Taylor BJ; Treon SP; Mant MJ; Reiman T; Belch AR; Pilarski LM
    Clin Cancer Res; 2007 Apr; 13(7):2005-13. PubMed ID: 17404080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray-Based Gene Expression Analysis Identifies Potential Diagnostic and Prognostic Biomarkers for Waldenström Macroglobulinemia.
    Xu H; Yao F
    Acta Haematol; 2018; 140(2):87-96. PubMed ID: 30227405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of interferon-alpha and -gamma on B cell differentiation in macroglobulinemia.
    Levy Y; Chedeville A; Brouet JC
    Leuk Lymphoma; 1996 Oct; 23(3-4):347-51. PubMed ID: 9031116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia.
    Sun H; Fang T; Wang T; Yu Z; Gong L; Wei X; Wang H; He Y; Liu L; Yan Y; Sui W; Xu Y; Yi S; Qiu L; Hao M
    J Transl Med; 2022 Dec; 20(1):576. PubMed ID: 36494694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy.
    Treon SP; Shima Y; Preffer FI; Doss DS; Ellman L; Schlossman RL; Grossbard ML; Belch AR; Pilarski LM; Anderson KC
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):97-106. PubMed ID: 10561024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical phenotyping of plasma cells in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia is comparable to flow cytometric techniques.
    Howard MT; Hodnefield J; Morice WG
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):96-8. PubMed ID: 21454202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotyping of Waldenströms macroglobulinemia cell lines reveals distinct patterns of surface antigen expression: potential biological and therapeutic implications.
    Paulus A; Chitta KS; Wallace PK; Advani PP; Akhtar S; Kuranz-Blake M; Ailawadhi S; Chanan-Khan AA
    PLoS One; 2015; 10(4):e0122338. PubMed ID: 25853860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle analysis of Waldenstrom's macroglobulinemia.
    Ocio EM; Mateo G; Vidriales B; Lopez-Berges MC; Garcia-Sanz R; Hernandez JM; Orfao A; San Miguel JF
    Clin Lymphoma; 2005 Mar; 5(4):250-2. PubMed ID: 15794858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma.
    Chng WJ; Schop RF; Price-Troska T; Ghobrial I; Kay N; Jelinek DF; Gertz MA; Dispenzieri A; Lacy M; Kyle RA; Greipp PR; Tschumper RC; Fonseca R; Bergsagel PL
    Blood; 2006 Oct; 108(8):2755-63. PubMed ID: 16804116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetics of familial Waldenstrom's macroglobulinemia: in pursuit of an understanding of genetic predisposition.
    McMaster ML; Giambarresi T; Vasquez L; Goldstein AM; Tucker MA
    Clin Lymphoma; 2005 Mar; 5(4):230-4. PubMed ID: 15794854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.
    Martín-Jiménez P; García-Sanz R; Balanzategui A; Alcoceba M; Ocio E; Sanchez ML; González M; San Miguel J
    Haematologica; 2007 May; 92(5):635-42. PubMed ID: 17488687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial predisposition to monoclonal gammopathy of unknown significance, Waldenström's macroglobulinemia, and multiple myeloma.
    Ogmundsdóttir HM; Einarsdóttir HK; Steingrímsdóttir H; Haraldsdóttir V
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):27-9. PubMed ID: 19362965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.